-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Buy on West Pharmaceutical Servs, Raises Price Target to $412

Benzinga·08/03/2026 18:52:44
语音播报
Citigroup analyst Joanne Wuensch maintains West Pharmaceutical Servs (NYSE:WST) with a Buy and raises the price target from $400 to $412.